These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9486905)

  • 1. Vocal evaluation of thyroplasty type I in the treatment of nonparalytic glottic incompetence.
    Lu FL; Casiano RR; Lundy DS; Xue JW
    Ann Otol Rhinol Laryngol; 1998 Feb; 107(2):113-9. PubMed ID: 9486905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal evaluation of vocal function after thyroplasty type I in the treatment of unilateral vocal paralysis.
    Lu FL; Casiano RR; Lundy DS; Xue JW
    Laryngoscope; 1996 May; 106(5 Pt 1):573-7. PubMed ID: 8628083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Longitudinal evaluation of vocal function following thyroplasty type I for the treatment of unilateral vocal paralysis].
    Lu F; Xue J; Casiano RR
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(5):300-3. PubMed ID: 9642367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial Vocal Fold Injection Predicts Thyroplasty Outcomes in Nonparalytic Glottic Incompetence.
    Dumberger LD; Overton L; Buckmire RA; Shah RN
    Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):279-283. PubMed ID: 28100072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thyroplasty type I on vocal fold vibration.
    Omori K; Slavit DH; Kacker A; Blaugrund SM; Kojima H
    Laryngoscope; 2000 Jul; 110(7):1086-91. PubMed ID: 10892675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-based outcomes in type I thyroplasty for nonparalytic glottic incompetence.
    Farzal Z; Overton LJ; Farquhar DR; Stephenson ED; Shah RN; Buckmire RA
    Laryngoscope; 2019 Nov; 129(11):2543-2548. PubMed ID: 30632159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [External vocal cord medialization: functional outcome].
    Friedrich G
    Laryngorhinootologie; 1998 Jan; 77(1):18-26. PubMed ID: 9522308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of acoustic characteristics of voice in patients after injection laryngoplasty with hyaluronan.
    Miaśkiewicz B; Szkiełkowska A; Piłka A; Skarżyński H
    Otolaryngol Pol; 2016 Feb; 70(1):15-23. PubMed ID: 26926304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional assessment of functional outcomes of medialization thyroplasty.
    Uloza V; Pribuisiene R; Saferis V
    Eur Arch Otorhinolaryngol; 2005 Aug; 262(8):616-21. PubMed ID: 16133469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laryngeal recovery following type I thyroplasty.
    Gorham MM; Avidano MA; Crary MA; Cotter CS; Cassisi NJ
    Arch Otolaryngol Head Neck Surg; 1998 Jul; 124(7):739-42. PubMed ID: 9677106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arytenoid adduction and type I thyroplasty in the treatment of aphonia.
    Slavit DH; Maragos NE
    J Voice; 1994 Mar; 8(1):84-91. PubMed ID: 8167793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III thyroplasty for the treatment of glottic gap in a patient undergoing laryngofissure cordectomy for squamous cell carcinoma of the vocal fold: technique and outcome.
    Kandogan T
    Ear Nose Throat J; 2010 Jun; 89(6):272-5. PubMed ID: 20556739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vocal fold atrophy and its surgical treatment.
    Isshiki N; Shoji K; Kojima H; Hirano S
    Ann Otol Rhinol Laryngol; 1996 Mar; 105(3):182-8. PubMed ID: 8615581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of vocal fold vibratory patterns in patients with unilateral vocal fold paralysis before and after type I thyroplasty with or without arytenoid adduction.
    Thompson DM; Maragos NE; Edwards BW
    Laryngoscope; 1995 May; 105(5 Pt 1):481-6. PubMed ID: 7760662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional voice outcomes after type I Gore-Tex thyroplasty in patients with nonparalytic glottic incompetence: a subgroup analysis.
    Shah RN; Deal AM; Buckmire RA
    Laryngoscope; 2013 Jul; 123(7):1742-5. PubMed ID: 23417369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of type I thyroplasty in the treatment of unilateral laryngeal paralysis. Apropos of 19 cases].
    Delol J; Maurice N; Makeïeff M; Arnoux B; Guerrier B
    Rev Laryngol Otol Rhinol (Bord); 1995; 116(4):293-8. PubMed ID: 8927832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of voice after implantation of hyaluronic acid to the vocal folds - preliminary report].
    Szkiełkowska A; Miaśkiewicz B; Remacle M; Skarzyński H
    Otolaryngol Pol; 2011; 65(6):436-42. PubMed ID: 22208941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask.
    Stow NW; Lee JW; Cole IE
    Otolaryngol Head Neck Surg; 2012 Feb; 146(2):266-71. PubMed ID: 22075075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgery of the laryngeal framework: type I thyroplasty].
    Guerrero J; Cobeta I; García-Díaz JD; Vegas A; Montojo J; Lorenzo F; Mate A
    Acta Otorrinolaringol Esp; 1998; 49(1):45-9. PubMed ID: 9557307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term voice outcomes after thyroplasty for unilateral vocal fold paralysis.
    Ryu IS; Nam SY; Han MW; Choi SH; Kim SY; Roh JL
    Arch Otolaryngol Head Neck Surg; 2012 Apr; 138(4):347-51. PubMed ID: 22431862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.